The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
about
Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related DiseasesThe Role of Infectious Agents in the Etiology of Ocular Adnexal NeoplasiaDNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors.Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.T-cell activation promotes tumorigenesis in inflammation-associated cancer.Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis.Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent mannerNF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis.I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma.NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signalingTrichothecin induces cell death in NF-κB constitutively activated human cancer cells via inhibition of IKKβ phosphorylation.A time to kill: targeting apoptosis in cancer.Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.Insulin-like growth factor receptor-1 and nuclear factor κB are crucial survival signals that regulate caspase-3-mediated lens epithelial cell differentiation initiation.Genome-wide homozygosity signature and risk of Hodgkin lymphoma.Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.Reversion of p-glycoprotein-mediated multidrug resistance in human leukemic cell line by diallyl trisulfideInhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells.Collections of simultaneously altered genes as biomarkers of cancer cell drug responsePostformulation peptide drug loading of nanostructures.Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.NF-kappaB and cancer-identifying targets and mechanisms.Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors.The HBZ gene, a key player in HTLV-1 pathogenesis.α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation.Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage responseTargeting HTLV-1 activation of NFκB in mouse models and ATLL patients.Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737.Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension.Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2.Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia.
P2860
Q26774352-C346E586-382E-46EB-8CB2-4CB2C010AA1EQ27486618-B6990923-D37C-47C4-A04E-F28ABC11BF60Q30931932-A9C76F5C-67CD-487F-841F-FB50D61D9F02Q33432788-D9C7C998-9FB9-485F-8AF9-C533B6143D17Q33581506-8C37A972-7916-49E4-8F30-ED94217D4F49Q33590130-ED6F7966-C59C-439B-B5AF-6A8AEAC53750Q33661771-D1F9E95B-74E3-47D1-A3EF-C4AED8A5D4D5Q33676065-B094137A-B4CC-433F-A241-8FAEC41FC2C0Q33985202-F032B42E-3907-47C2-98D5-93717232600DQ34133753-5C3D5904-E05A-4C7D-8EB9-0CCD33254583Q34143653-CE4EBDDF-2E82-472D-9AA1-943FD0DBCBEFQ34381627-4D051F79-1F57-4462-8338-B9BA2CF2EC3FQ34926660-05098077-8490-4C3E-9522-B7EE62E8F267Q35138968-2C90758F-1FF5-484F-8627-0AB538C80F1FQ35160414-6165660C-562E-495F-8853-2CF5D6E844EDQ35261245-22456E4A-204B-4275-ADBE-8899A8A30BABQ36054645-8977726C-42E7-4E36-9F59-A0E555668223Q36099366-C90FE1F7-5ED3-4141-B022-6148BB8BA80AQ36147455-06C74DAF-7D2D-460B-870E-8BBBAD26C39FQ36163183-2FDB470A-9030-4A48-9B19-1F2A10E867B1Q36424037-51760162-3BC6-444B-8F79-6EE0260EFA25Q36698868-42583952-91CF-40B9-8721-0AF4C7365D41Q36780035-7098A934-65A9-478A-A2C3-2CAC97487EF4Q36935112-C2A227D4-482F-45F7-AFBA-F4A0CA12DCD9Q36984251-CBDDC8BB-FE1C-488A-9C7A-2B04CD56B1DFQ37100728-5668780C-4496-46CD-8AED-9AD6B3F7461AQ37317982-0E7A385D-6CE7-4FAD-AE9B-AA7B574B6270Q37583421-F85730B0-8217-4EE4-8B96-AD1A9CBCFF2EQ37657776-4A8F60F0-D88E-4712-85DB-85E71E6EE67EQ37707633-7F92EA04-CB29-4CA7-96DC-91282240AF1AQ37945228-7A6DFC93-B49F-4AC3-9CE2-CD3FE99FB9D8Q39832788-E0C963F7-25D9-4FE6-AE61-7EEF3E6B12EAQ40090310-AAD3610F-2860-4789-A7FF-5CD8804FAA2CQ40783358-4483E45D-6AD3-4054-AA7F-2FDEDA2143EEQ41900857-E6CCCF66-129B-46C1-B19A-BE854328C66CQ42378092-8B29017E-1A13-4096-AF63-9CC0E06890F7Q42738684-9446A5D3-CEA2-418A-AD1B-1976FE844FF4Q42921947-8C8BE917-5FB6-42CA-8972-1AC4007B22AEQ51075776-92C63A07-EDCD-4F8E-949E-A6D76E942DD0Q52592925-E4C40605-3BAE-4152-88C2-1B495F277956
P2860
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@ast
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@en
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@nl
type
label
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@ast
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@en
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@nl
prefLabel
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@ast
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@en
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@nl
P2860
P356
P1476
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
@en
P2093
Lee Ratner
Leon Bernal-Mizrachi
P2860
P304
P356
10.1073/PNAS.0507809103
P407
P577
2006-06-02T00:00:00Z